Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. VBI Vaccines Inc.
  6. Company
    VBIV   CA91822J1030

VBI VACCINES INC.

(VBIV)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo VBI Vaccines Inc.
VBI Vaccines Inc. is a development-stage biotechnology company. The Company's principal products include cytomegalovirus (CMV) Vaccine Candidate, enveloped Virus Like Particle (eVLP) Vaccine Platform and Lipid Particle Vaccine (LPV) Vaccine Platform. The Company is also engaged in the research and development (R and D) activity. The Company's subsidiaries includes Variation Biotechnologies (US), Inc. (VBI US) and Variation Biotechnologies Inc. (VBI Cda).

Number of employees : 127 people.
Sales per Business
20192020Delta
USD (in Million)%USD (in Million)%
Research & Development Service1.6975.9%0.77873.3% -53.83%
Vaccines0.53624.1%0.28326.7% -47.2%
Sales per region
20192020Delta
USD (in Million)%USD (in Million)%
China/Hong Kong1.6473.6%0.72468.2% -55.72%
Israel0.45520.5%0.28426.8% -37.58%
Europe0.1315.9%0.0535% -59.54%
Managers
NameAgeSinceTitle
Jeff Baxter582016President, Chief Executive Officer & Director
Christopher McNulty432019CFO, Director & Head-Business Development
David Evander Anderson, Dr.502016Chief Scientific Officer
Francisco Diaz-Mitoma, Dr.652016Chief Medical Officer
Steven H. Gillis, Dr.672016Chairman
Michel de Wilde, Dr.702016Independent Director
Blaine H. McKee, Dr.552019Independent Director
Joanne Cordeiro622019Independent Director
Damian Braga642020Independent Director
Nicole Anderson-2019Director-Corporate Communications & IR
Members of the board
NameAgeSinceTitle
Steven H. Gillis, Dr.672016Chairman
Jeff Baxter582016President, Chief Executive Officer & Director
Michel de Wilde, Dr.702016Independent Director
Christopher McNulty432019CFO, Director & Head-Business Development
Blaine H. McKee, Dr.552019Independent Director
Joanne Cordeiro622019Independent Director
Damian Braga642020Independent Director
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 254,195,435 190,185,281 74.8% 0 0.0% 74.8%
Shareholders
NameEquities%
Perceptive Advisors LLC 55,688,713 21.9%
SSgA Funds Management, Inc. 22,293,634 8.77%
ARCH Venture Partners LLC 13,026,057 5.12%
Viking Global Investors LP 8,798,971 3.46%
BlackRock Fund Advisors 5,720,985 2.25%
Menora Mivtachim Insurance Ltd. 5,259,868 2.07%
The Vanguard Group, Inc. 4,829,116 1.90%
BVF Partners LP 4,722,572 1.86%
Geode Capital Management LLC 3,480,327 1.37%
Northern Trust Investments, Inc.(Investment Management) 2,060,930 0.81%
Company contact information
VBI Vaccines, Inc.
222 3rd Street
Suite 2241
Cambridge, MA 02142

Phone : +1.617.830.3031
Web : http://www.vbivaccines.com
Sector Other Biotechnology & Medical Research
1st jan.Capitalization (M$)
VBI VACCINES INC.41.82%991
MODERNA, INC.102.97%85 140
LONZA GROUP AG13.57%52 316
IQVIA HOLDINGS INC.35.24%46 441
CELLTRION, INC.-22.42%33 893
SEAGEN INC.-10.43%28 470
PHARMARON BEIJING CO., LTD.73.47%25 331
HANGZHOU TIGERMED CONSULTING CO., LTD16.47%25 232
CUREVAC N.V.-29.80%21 497
ALNYLAM PHARMACEUTICALS, INC.34.36%20 527
INCYTE CORPORATION-2.17%18 722
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.46.86%18 440
BIO-TECHNE CORPORATION39.96%17 285
PPD, INC.35.24%16 253
NOVAVAX, INC.72.40%14 239
ICON PUBLIC LIMITED COMPANY8.07%11 139
QIAGEN N.V.-10.48%10 806
PRA HEALTH SCIENCES, INC.32.78%10 792
CRISPR THERAPEUTICS AG-14.65%10 471
GENSCRIPT BIOTECH CORPORATION207.62%8 910
SYNEOS HEALTH, INC.24.75%8 782